Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6016)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2018 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu YW, De Keyzer F, Feng YB, Chen F, Song SL, Swinnen J, Bormans G, Oyen R, Huang G, Ni YC. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers. World J Gastroenterol 2018; 24(25): 2710-2721 [PMID: 29991876 DOI: 10.3748/wjg.v24.i25.2710] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i25/2710.htm |
| Number | Citing Articles |
| 1 |
Li Liu, Devin O’Kelly, Regan Schuetze, Graham Carlson, Heling Zhou, Mary Lynn Trawick, Kevin G. Pinney, Ralph P. Mason. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors. Molecules 2021; 26(9): 2551 doi: 10.3390/molecules26092551
|
| 2 |
Danping Huang, Ruimeng Yang, Yong Zou, Hongmei Lin, Xiangdong Xu, Xinhua Wei, Hanzheng Chang, Liqiong Wu, Wenshuang Ding, Wenjie Tang, Xinqing Jiang, Antonio Giovanni Solimando. Treatment Effect of a Vascular-Disrupting Agent Dynamically Monitored by DWI: An Animal Experimental Study. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/2909189
|
| 3 |
Yongjian Guo, Mingjun Bai, Liteng Lin, Jingjun Huang, Yongcheng An, Licong Liang, Yaohong Liu, Wensou Huang. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomedicine & Pharmacotherapy 2019; 118: 109272 doi: 10.1016/j.biopha.2019.109272
|
| 4 |
Yewei Liu, Qiu Guan, Xiangyong Kong, Frederik De Keyzer, Yuanbo Feng, Feng Chen, Jie Yu, Jianjun Liu, Shaoli Song, Jos van Pelt, Johan Swinnen, Guy Bormans, Raymond Oyen, Shuncong Wang, Gang Huang, Yicheng Ni, Yue Li. Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI. Translational Oncology 2020; 13(1): 92 doi: 10.1016/j.tranon.2019.09.010
|
| 5 |
Yewei Liu, Shuncong Wang, Xiaohui Zhao, Yuanbo Feng, Guy Bormans, Johan Swinnen, Raymond Oyen, Gang Huang, Yicheng Ni, Yue Li. Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation. Diagnostics 2020; 10(2): 78 doi: 10.3390/diagnostics10020078
|
| 6 |
Fanhua Meng, Biao Zou, Rong Yang, Qingqing Duan, Ting Qian. The diagnostic efficiency of the perfusion-related parameters in assessing the vascular disrupting agent (CA4P) response in a rabbit VX2 liver tumor model. Acta Radiologica 2022; 63(9): 1147 doi: 10.1177/02841851211032450
|